Status:
RECRUITING
Metformin and Lactoferrin in Sepsis in Icu
Lead Sponsor:
Tanta University
Conditions:
Sepsis
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
PHASE3
Brief Summary
Sepsis is a life-threatening organ dysfunction triggered by an unregulated response of a host to infection. Sepsis is a reason for substantial mortality and morbidity among intensive care unit (ICU) p...
Detailed Description
Sepsis is a life-threatening organ dysfunction triggered by an unregulated response of a host to infection. Sepsis is a reason for substantial mortality and morbidity among intensive care unit (ICU) p...
Eligibility Criteria
Inclusion
- Age more than 18 years old.
- A diagnosis of sepsis according to the latest Sepsis definition.11
- Estimated GFR \>45 ml/minute.
Exclusion
Key Trial Info
Start Date :
April 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 9 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06181422
Start Date
April 1 2024
End Date
June 9 2024
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta
Tanta, Egypt